A presidential decree signed on May 5 introduces new measures to support the private sector in healthcare. According to the decree, the Pharmaceutical Industry Development Agency under the Ministry of Health has been renamed the Medical and Pharmaceutical Industry Development Agency.

Starting September 1, 2026, the agency will be assigned additional tasks. In particular, it will establish Health Invest as a joint-stock company. The company's charter capital will be set at 10 billion soums, funded by the Medical Organizations Development Fund.

A Medical Organizations Development Fund will be created under the agency without forming a legal entity. The fund's resources will be used to modernize state medical institutions and improve management efficiency.

By the end of 2026, as a pilot project, four institutions will be transferred to Health Invest's management: the Jizzakh Regional Multidisciplinary Medical Center, the National Children's Medical Center, the National Medical Center, and the Multidisciplinary Medical Center, along with the territory of the LLC. This aims to introduce modern management models.

The agency, together with the Ministry of Health and the Ministry of Economy and Finance, and with the involvement of foreign experts, must develop and approve a strategy to improve the efficiency of managing state medical institutions by April 1, 2027.

Source: www.gazeta.uz